Alzheimer`s drugmaker says lack of funding, Covid outbreak forced to shut PhIII
16 May 2022 //
ENDPTS
Trial for controversial China-made Alzheimer’s drug aborted
14 May 2022 //
FIERCEPHARMA
Green Valley`s seaweed-derived Alzheimer`s drug is halted in PhIII study
10 May 2022 //
ENDPTS
FDA Approves Green Valley`s IND for Sodium Oligomannate`s Global Phase II Trial
17 Jan 2022 //
PRNEWSWIRE